2605, 2016

Europese commissie keurt Elozutumab goed

By |mei 26th, 2016|Categorieën: nieuws|0 Reacties

The European Commission approved elotuzumab in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma (MM) in patients who have received at least one prior therapy. The approval was based on the results

Ga naar de bovenkant